Home / Biosimilars

Biosimilars

News

Hospira launches infliximab biosimilar in major European markets posted 06/03/2015

Injectable generics specialist and biosimilars maker Hospira announced on 16 February 2015 that it was launching its inflixim...

FDA delays meeting to evaluate infliximab biosimilar posted 27/02/2015

The US Food and Drug Administration (FDA) has postponed a meeting of its Arthritis Advisory Committee, which was to discuss a...

Accord launches biosimilar filgrastim in Europe posted 27/02/2015

Generics company Accord Healthcare (Accord) has announced the launch of their first European approved biosimilar Accofil (fil...

Hospira and Pfenex to collaborate on ranibizumab biosimilar posted 23/02/2015

US-based injectables specialist Hospira and US biotechnology firm Pfenex announced on 10 February 2015 that they had entered...

FDA advisers to consider infliximab biosimilar posted 23/02/2015

The US Food and Drug Administration (FDA) revealed in a Federal Register publication on 10 February 2015 that it has asked ad...

 

Research

Comparison of non-originator filgrastim with Neupogen finds no difference in neutropenia recovery periods posted 06/03/2015

Results of an observational study found no difference in Biocad’s non-originator filgrastim (Leucostim) compared to Neupogen...

Generics and off-patent biologicals for cancer treatment in developing countries posted 02/03/2015

The understandable focus on infectious diseases, such as human immunodeficiency virus (HIV), malaria and tuberculosis (TB), h...

Positive phase III data for Amgen adalimumab biosimilar posted 27/02/2015

US biopharmaceutical giant Amgen announced on 3 February 2015 positive results from its phase III clinical trial for a biosim...

Biosimilars compared to generics in the European market posted 16/02/2015

Once a patent expires, price competition is possible since any manufacturer can copy the originator product. This circumstanc...

Impact of nephrology subsequent entry biologics in Canada posted 16/02/2015

Subsequent entry biologics (SEBs) may soon be a reality in Canadian nephrology practice. Along with opportunities to reduce h...

 

General

What happened in biosimilars during 2014 posted 06/03/2015

Many new developments have taken place in the biosimilars industry in 2014 [1]. One of the most important milestones during 2...

Biosimilars of rituximab posted 27/02/2015

Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune syste...

Biosimilars approved in Europe posted 27/02/2015

Last update: 27 February 2015In the European Union (EU), a legal framework for approving biosimilars was established in 2003....

Biosimilars of adalimumab posted 27/02/2015

Last update: 20 February 2015Adalimumab is a human monoclonal antibody that treats autoimmune diseases by inhibiting tumour n...

Biosimilars of pegfilgrastim posted 27/02/2015

Last update: 20 February 2015Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor...

Generics News Research General

more

Biosimilars News Research General

more